DDIT3 and Parkinson disease: The increased levels of UPR markers like BiP, p-eIF2α, CHOP, p-IRE1, XBP1s, and p-c-Jun were evidenced in in vitro and in vivo models of PD submitted to 6-OHDA treatment [13,21,22].